Tarsus Pharmaceuticals

Filed a patent for "isoxazoline parasiticide formulations and methods for treating blepharitis" on Fri, February 10, 2023

Filed a patent for "ophthalmic compositions for treating ocular demodex using lotilaner formulations" on Thu, November 10, 2022

Filed a patent for "methods for treating ocular demodex using lotilaner formulations" on Thu, November 17, 2022

Filed a patent for "methods for treating demodex blepharitis using lotilaner formulations" on Thu, November 10, 2022

Filed a patent for "methods for treating ocular demodex using spinosad formulations" on Thu, June 22, 2023

Filed a patent for "systemic isoxazoline parasiticides for vector-borne and viral disease treatment or prophylaxis" on Thu, July 13, 2023

Filed a patent for "isoxazoline parasiticide formulations and methods for treating blepharitis" on Thu, September 21, 2023

Filed a patent for "isoxazoline parasiticide formulations and methods for treating blepharitis" on Thu, September 28, 2023